243 related articles for article (PubMed ID: 27983891)
1. User-Friendly Technology the Key to Gene-Editing's Bloom: Market for Gene-Editing Tools Estimated at $608m and Growing as New Applications Are Found.
Carlson B
Hum Gene Ther Clin Dev; 2016 Dec; 27(4):137-139. PubMed ID: 27983891
[No Abstract] [Full Text] [Related]
2. The Future of Genome Editing.
Cell; 2018 May; 173(6):1311-1313. PubMed ID: 29856947
[TBL] [Abstract][Full Text] [Related]
3. Could CRISPR be the solution for gene editing's Gordian knot?
Fang H; Wang W
Cell Biol Toxicol; 2016 Dec; 32(6):465-467. PubMed ID: 27614448
[No Abstract] [Full Text] [Related]
4. Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease.
Doetschman T; Georgieva T
Circ Res; 2017 Mar; 120(5):876-894. PubMed ID: 28254804
[TBL] [Abstract][Full Text] [Related]
5. Gene editing based hearing impairment research and therapeutics.
Kang W; Sun Z; Zhao X; Wang X; Tao Y; Wu H
Neurosci Lett; 2019 Sep; 709():134326. PubMed ID: 31195050
[TBL] [Abstract][Full Text] [Related]
6. The clinical cutting edge.
Nat Biotechnol; 2020 Jul; 38(7):767. PubMed ID: 32641850
[No Abstract] [Full Text] [Related]
7. [A new toolbox for genome editing].
Jordan B
Med Sci (Paris); 2017 Jan; 33(1):105-108. PubMed ID: 28120767
[TBL] [Abstract][Full Text] [Related]
8. A CRISPR edit for heart disease.
King A
Nature; 2018 Mar; 555(7695):S23-S25. PubMed ID: 29517035
[No Abstract] [Full Text] [Related]
9. The Daunting Economics of Therapeutic Genome Editing.
Wilson RC; Carroll D
CRISPR J; 2019 Oct; 2(5):280-284. PubMed ID: 31599686
[TBL] [Abstract][Full Text] [Related]
10. Ji Luo Elucidates the CRISPR Gene Editing Technology, and How It May Affect Cancer Therapy in the Future.
Luo J
Oncology (Williston Park); 2016 Oct; 30(10):879. PubMed ID: 27753053
[No Abstract] [Full Text] [Related]
11. Therapeutic genome editing with engineered nucleases.
Haas SA; Dettmer V; Cathomen T
Hamostaseologie; 2017 Jan; 37(1):45-52. PubMed ID: 28070592
[TBL] [Abstract][Full Text] [Related]
12. CRISPR/Cas9 gene-editing: Research technologies, clinical applications and ethical considerations.
Memi F; Ntokou A; Papangeli I
Semin Perinatol; 2018 Dec; 42(8):487-500. PubMed ID: 30482590
[TBL] [Abstract][Full Text] [Related]
13. Delivery technologies for genome editing.
Yin H; Kauffman KJ; Anderson DG
Nat Rev Drug Discov; 2017 Jun; 16(6):387-399. PubMed ID: 28337020
[TBL] [Abstract][Full Text] [Related]
14. How CRISPR gene editing could help treat Alzheimer's.
Thompson T
Nature; 2024 Jan; 625(7993):13-14. PubMed ID: 38082131
[No Abstract] [Full Text] [Related]
15. Genome Editing: Past, Present, and Future.
Carroll D
Yale J Biol Med; 2017 Dec; 90(4):653-659. PubMed ID: 29259529
[TBL] [Abstract][Full Text] [Related]
16. Gene editing using CRISPR-Cas9 for the treatment of lung cancer.
Castillo A
Colomb Med (Cali); 2016 Dec; 47(4):178-180. PubMed ID: 28293040
[No Abstract] [Full Text] [Related]
17. [Research progress in the third-generation genomic editing technology - CRISPR/Cas9].
Zhou Y; Zong Y; Kong X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2016 Oct; 33(5):713-6. PubMed ID: 27577230
[TBL] [Abstract][Full Text] [Related]
18. [CRISPR-Cas system as molecular scissors for gene therapy].
Heinz GA; Mashreghi MF
Z Rheumatol; 2017 Feb; 76(1):46-49. PubMed ID: 28124743
[TBL] [Abstract][Full Text] [Related]
19. CRISPR-Cas9: a promising tool for gene editing on induced pluripotent stem cells.
Kim EJ; Kang KH; Ju JH
Korean J Intern Med; 2017 Jan; 32(1):42-61. PubMed ID: 28049282
[TBL] [Abstract][Full Text] [Related]
20. Treatment of heritable diseases using CRISPR: Hopes, fears, and reality.
Kofler N; Kraschel KL
Semin Perinatol; 2018 Dec; 42(8):515-521. PubMed ID: 30420296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
